Furthermore, the combined expression of P- and E-cadherin was significantly associated with the histological grade of the tumours, with the majority (90%) of grade II and III carcinomas exhibiting a P+/E+ or P+/E− immunophenotype. The gene discussed is CDH1; the disease is neoplasm.